HAE 10-Q: SEC filing
Haemonetics Corporation
Filed with the SEC on · accession 0000313143-26-000152
HAE filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -2.6% by the first close after the filing.
Summary of the filing
Haemonetics Corporation filed its quarterly report on Form 10-Q for the fiscal quarter ended September 26, 2026, reporting routine financial results and disclosures.
Key details
How HAE stock reacted
Close before
$127.42
Nov 4, 2026
First close after
-2.60%
$124.11
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for HAE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for HAE?
Click hereFrequently asked questions
What did HAE file with the SEC on Nov 5, 2026?
HAE filed a 10-Q (SEC filing). Haemonetics Corporation filed its quarterly report on Form 10-Q for the fiscal quarter ended September 26, 2026, reporting routine financial results and disclosures.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did HAE stock react to this filing?
HAE closed at $127.42 before the filing and $124.11 on Nov 5, 2026 (-2.60%).
Other HAE SEC filings
Get alerts when HAE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days